VYTRUS BIOTECH

Trading sesion


11/06/2025 Close

3.9600

Last price


30.23 mill. €

Capitalisation

0.00

Dif.(%)


83.33

% Year 2025

Last Trade

Date

11/06/2025

Hour

Close

Last

3.9600

Ref.

3.9600

Dif.(%)

0.00

Volume (Shares)

4,731

Turnover (€x1000)

18.91

X
11/06/2025 16:00:13
BidAsk
OrdersVolumePricePriceVolumeOrders
13503.96003.96003301

Security

Security name

VYTRUS BIOTECH

Ticker

VYT

ISIN

ES0105618005

NIF

A-65118531

Shares Admitted

7.635.100

Nominal

0,01 Euros

Capital Admitted

76.351,00 Euros

Trading

Fixing

Liquidity Provider

GVC GAESCO VALORES, S.V., S.A.

Registered Advisor

GVC GAESCO VALORES, S.V., S.A.

Auditor

RSM SPAIN AUDITORES S.L.P.

Address

SANT GAIET 121, 08221 TERRASSA, BARCELONA

Contact

investors@vytrus.com

Historical Summary

 2022202320242025 until 11/06

Capital Admitted (thousands of euros)

71717676

Shares (x 1,000)

7,1157,1157,6357,635

Period Close Price (euros)

3.40001.86002.16003.9600

Period Last Price (euros)

3.40001.86002.16003.9600

Period High Price (euros)

4.00003.50002.60004.0800

Period Low Price (euros)

2.06001.78001.84002.1200

Capitalisation (thousands of euros)

24,19113,23416,49230,235

Volume (thousands of shares)

541367833372

Turnover (thousands of euros)

1,7659571,8981,088

"Our biotech platform of plant stem cell cultivations creates a new paradigm in dermo-cosmetics: beauty as a consequence of health and not the other way around."

Company Profile

Vytrus Biotech's goal is to be a benchmark in the dermo-cosmetic ingredients sector in innovation and sustainability through our biotechnological platforms of plant stem cell cultures. We promote skin health to improve people's appearance and well-being.

At Vytrus Biotech we develop, produce and market worldwide high value-added active ingredients in the dermo-cosmetic market. Plant stem cell technology has enormous potential not only in dermo-cosmetics but also in other sectors such as veterinary medicine, functional food and pharmaceuticals.

For the first time, technology and nature can be combined in a single product. Vytrus Biotech's biotechnology gives it a competitive advantage over traditional plant extracts. We obtain highly effective, sustainable and safe products, generating savings of more than 99% in natural resources and contributing to the preservation of the planet's biodiversity.

Other Relevant Information

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.